Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
THC · against 103 other Healthcare companies of similar size
Ranked #24 of 104 · scores higher than 76% of peers
Bars: peers in each 10-point band of the profitability score26 peers with a profitability score of 90–100, including THC · Click a bar to see the companies
Mainly thanks to its return on assets, return on invested capital and operating margin, which are stronger than most Healthcare peers.
| Metric | THC | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 102 reported | 22.8% | 11.9% | 79% | 33% | |
| Operating marginHigher is better · 103 reported | 20.8% | 17.1% | 67% | 33% | |
| Return on assetsHigher is better · 100 reported | 10.3% | 6.3% | 80% | 33% | |
| Return on equityHigher is better · 97 reported | 37.3% | 11.7% | 90% | Context only | |
| Gross marginHigher is better · 106 reported | 41.7% | 61.4% | 27% | Context only |
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 17.9B USD | 99 | 76 | |
| 1 | 13.9B EUR (≈$15.3B) | 99 | 78 | |
| 1 | 20.0B AUD (≈$13.2B) | 99 | 77 | |
| 4 | 23.8B USD | 98 | 84 | |
| 5 | 193.6B HKD (≈$24.8B) | 97 | 78 | |
| 22 | 16.8B USD | 91 | 75 | |
| 22 | 28.6B USD | 91 | 60 | |
| 24 | 10.7B USD | 90 | 65 | |
| 24 | 16.1B CHF (≈$18.5B) | 90 | 54 | |
| 24 | 21.5B USD | 90 | 60 | |
| 27 | 111.7B DKK (≈$16.8B) | 89 | 53 | |
| 27 | 36.0B USD | 89 | 46 | |
| 27 | 14.4B USD | 89 | 71 | |
| 30 | 34.6B USD | 88 | 58 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score